文献速递贫血与红细胞疾病MDS 与骨髓增殖性肿瘤

成人再生障碍性贫血中红系发育异常的临床影响与特征:多中心登记研究结果

Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registry.
PubMed 文献 · Br J Haematol · 2024-01-31

该多中心登记研究纳入100例无环形铁粒幼细胞的成人再生障碍性贫血(AA)患者,其中32例存在红系发育异常(AA伴轻微发育异常)。红系发育异常与性别、年龄无显著差异,在重型/极重型及非重型AA中,抗胸腺细胞球蛋白+环孢素12个月内反应率及总生存、无白血病生存均无显著差异,提示红系发育异常不影响临床特征或结局,不应据此排除AA诊断。

要点

  • 100例AA患者中32例存在红系发育异常,与性别、年龄无显著差异。
  • 重型/极重型AA中,伴红系发育异常者12个月内反应率80.0%,不伴者42.9%(p=0.29)。
  • 非重型AA中,伴红系发育异常者反应率60.0%,不伴者90.0%(p=0.24)。

核心结论

  • 红系发育异常的存在未显著影响AA患者的临床特征或结局,在AA中出现是可接受的,不应排除AA诊断。

研究设计与样本

  • 多中心登记研究,纳入100例无环形铁粒幼细胞的合格成人AA患者,其中32例有红系发育异常(AA伴轻微发育异常)。

主要发现

  • AA伴与不伴红系发育异常组间性别和年龄无显著差异。
  • 重型/极重型AA中,抗胸腺细胞球蛋白+环孢素12个月内反应率:伴红系发育异常组80.0% vs 不伴组42.9%(p=0.29)。
  • 非重型AA中,抗胸腺细胞球蛋白+环孢素12个月内反应率:伴红系发育异常组60.0% vs 不伴组90.0%(p=0.24)。
  • 总生存和无白血病生存两组间无显著差异。

关键数值与推荐

  • 红系发育异常定义为红系形态发育异常达到10%阈值。
  • 重型/极重型AA伴红系发育异常组反应率80.0% vs 不伴组42.9%(p=0.29)。
  • 非重型AA伴红系发育异常组反应率60.0% vs 不伴组90.0%(p=0.24)。

临床怎么用

  • 原文结论指出红系发育异常不应排除AA诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Morphological dysplasia in haematopoietic cells, defined by a 10% threshold in each lineage, is one of the diagnostic criteria for myelodysplastic neoplasms. Dysplasia limited to the erythroid lineage has also been reported in some cases of aplastic anaemia (AA); however, its significance remains unclear. We herein examined the impact of erythroid dysplasia on immunosuppressive therapy responses and survival in AA patients. The present study included 100 eligible AA patients without ring sideroblasts. Among them, 32 had dysplasia in the erythroid lineage (AA with minimal dysplasia [mini-D]). No significant sex or age differences were observed between AA groups with and without erythroid dysplasia. In severe/very severe AA and non-severe AA patients, a response to anti-thymocyte globulin + ciclosporin within 12 months was observed in 80.0% and 60.0% of AA with mini-D and 42.9% and 90.0% of those without dysplasia, with no significant difference (p = 0.29 and p = 0.24 respectively). Overall survival and leukaemia-free survival did not significantly differ between the groups. Collectively, the present results indicate that the presence of erythroid dysplasia did not significantly affect clinical characteristics or outcomes in AA patients, suggesting that its presence in AA is acceptable. Therefore, erythroid dysplasia should not exclude an AA diagnosis.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Maeda T, Matsuda A, Kanda J, et al. Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registry. Br J Haematol. 2024. PMID: 38296352. doi:10.1111/bjh.19323

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。